PT1045702E - Métodos de controlo da diferenciação e do crescimento celulares utilizando uma proteína de fusão e um fármaco - Google Patents

Métodos de controlo da diferenciação e do crescimento celulares utilizando uma proteína de fusão e um fármaco Download PDF

Info

Publication number
PT1045702E
PT1045702E PT99902103T PT99902103T PT1045702E PT 1045702 E PT1045702 E PT 1045702E PT 99902103 T PT99902103 T PT 99902103T PT 99902103 T PT99902103 T PT 99902103T PT 1045702 E PT1045702 E PT 1045702E
Authority
PT
Portugal
Prior art keywords
methods
drug
growth
fusion protein
cell differentiation
Prior art date
Application number
PT99902103T
Other languages
English (en)
Inventor
Carl Anthony Blau
David M Spencer
Original Assignee
Univ Leland Stanford Junior
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior, Univ Washington filed Critical Univ Leland Stanford Junior
Publication of PT1045702E publication Critical patent/PT1045702E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/033—Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the internal surface of the plasma membrane, e.g. containing a myristoylation motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/71—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16
    • C07K2319/715—Fusion polypeptide containing domain for protein-protein interaction containing domain for transcriptional activaation, e.g. VP16 containing a domain for ligand dependent transcriptional activation, e.g. containing a steroid receptor domain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Environmental Sciences (AREA)
  • Microbiology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT99902103T 1998-01-08 1999-01-07 Métodos de controlo da diferenciação e do crescimento celulares utilizando uma proteína de fusão e um fármaco PT1045702E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7075498P 1998-01-08 1998-01-08
US7089398P 1998-01-09 1998-01-09
US10288898P 1998-10-02 1998-10-02

Publications (1)

Publication Number Publication Date
PT1045702E true PT1045702E (pt) 2008-06-24

Family

ID=27371764

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99902103T PT1045702E (pt) 1998-01-08 1999-01-07 Métodos de controlo da diferenciação e do crescimento celulares utilizando uma proteína de fusão e um fármaco

Country Status (11)

Country Link
US (1) US7754202B1 (pt)
EP (1) EP1045702B1 (pt)
AT (1) ATE388724T1 (pt)
AU (1) AU2215999A (pt)
CA (1) CA2318571C (pt)
CY (1) CY1108126T1 (pt)
DE (1) DE69938335T2 (pt)
DK (1) DK1045702T3 (pt)
ES (1) ES2303372T3 (pt)
PT (1) PT1045702E (pt)
WO (1) WO1999034836A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ078799A0 (en) * 1999-06-04 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. New use
US20050238628A1 (en) * 2004-04-08 2005-10-27 Blau Carl A Methods for treating cancer
US20190054117A1 (en) * 2014-12-19 2019-02-21 Novartis Ag Dimerization switches and uses thereof
US11325948B2 (en) 2016-03-19 2022-05-10 Exuma Biotech Corp. Methods and compositions for genetically modifying lymphocytes to express polypeptides comprising the intracellular domain of MPL

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1978095A1 (en) * 1993-02-12 2008-10-08 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptor proteins for controlling signal transduction and ligands binding thereto
US5834266A (en) * 1993-02-12 1998-11-10 President & Fellows Of Harvard College Regulated apoptosis
US6150527A (en) * 1994-08-18 2000-11-21 Ariad Pharmaceuticals, Inc. Synthetic multimerizing agents
AU3968595A (en) * 1994-10-25 1996-05-15 Board Of Trustees Of The Leland Stanford Junior University Conditional transformation of genetically engineered cells
US5741899A (en) * 1995-02-02 1998-04-21 Cell Genesys, Inc. Chimeric receptors comprising janus kinase for regulating cellular pro liferation
US6506379B1 (en) 1995-06-07 2003-01-14 Ariad Gene Therapeutics, Inc. Intramuscular delivery of recombinant AAV

Also Published As

Publication number Publication date
DE69938335D1 (de) 2008-04-24
EP1045702B1 (en) 2008-03-12
ATE388724T1 (de) 2008-03-15
CY1108126T1 (el) 2014-02-12
EP1045702A4 (en) 2002-12-04
DK1045702T3 (da) 2008-07-14
WO1999034836A1 (en) 1999-07-15
DE69938335T2 (de) 2009-04-23
ES2303372T3 (es) 2008-08-01
US7754202B1 (en) 2010-07-13
EP1045702A1 (en) 2000-10-25
CA2318571A1 (en) 1999-07-15
CA2318571C (en) 2010-08-17
AU2215999A (en) 1999-07-26

Similar Documents

Publication Publication Date Title
AU3462899A (en) Sequence and method for genetic engineering of proteins with cell membrane translocating activity
AU4336499A (en) Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
CA2147626A1 (en) Cell Encapsulating Device
DE3852823D1 (de) Transduktionsveränderte fibroblasten und ihre anwendung.
SG47996A1 (en) Method for culturing animal cells under embedded conditions
WO1997044065A3 (en) Device and method for encapsulated gene therapy
HK1017903A1 (en) Process for controlling sialylation of proteins produced by mammalian cell culture.
NZ504511A (en) Recombinant proteins comprising fused first and second distinct site specific recombinase and use in methods for the integration of foreign DNA into eukaryotic genomes
NZ333786A (en) Bioreactor for mammalian cells comprising a flow restrictor which maintains the cell density at near tissue levels
PT2374872E (pt) Método para aumentar a expressão de altos rendimentos de proteínas de fusão ativas de um membro da família de recetor tnf, e sua purificação
AU6131198A (en) Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells
EP0671469A3 (en) Support penetrating a cell culture medium, culture method and apparatus using this support.
ATE342275T1 (de) Vorübergehend-immortalisierte zellen zur verwendung in gentherapie
GB2306761B (en) Electrode materials suitable for electrochemical cells
WO1999063063A8 (en) Cellular proteins which mediate herpesvirus entry
EP1045702A4 (en) TECHNIQUES FOR ACTING ON CELL DIFFERENTIATION AND GROWTH USING A FUSION PROTEIN AND A MEDICAMENT
DE69333954D1 (de) An der streptogramin biosynthese beteiligte polypeptide, ihre kodierenden nukleotidsequenzen und ihre verwendung
ES2132025A1 (es) Proteinas urag de las plantas.
AU2520595A (en) Virosome-mediated intracellular delivery of therapeutic agents
FR2716205B1 (fr) Récepteur galanine, acides nucléiques, cellules transformées et utilisations.
AU2002303277A1 (en) Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
GB2353531A (en) Conditional mutants of influenza virus M2 protein
HK1045715B (zh) 培養細胞的方法
ATE302264T1 (de) Freigabe von intrazellulärem material
WO2001013446A2 (fr) Materiau pour electrode positive de pile secondaire au lithium et son procede de preparation